ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,789Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 97

$504K Total Retail Price of All Prescriptions

Rank: 26 out of 97

520 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 520 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 520 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 8,777 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 508 480 1 1
FUROSEMIDE 452 431 2 3
SIMVASTATIN 369 326 3 2
OMEPRAZOLE 321 282 4 5
LISINOPRIL 320 292 5 4
METOPROLOL TARTRATE 282 271 6 7
POTASSIUM CHLORIDE 241 229 7 10
AMLODIPINE BESYLATE 227 216 8 6
SERTRALINE HCL 205 202 9 16
HYDROCHLOROTHIAZIDE 196 175 10 9
METFORMIN HCL 196 179 10 12
ATORVASTATIN CALCIUM 142 137 12 14
METOPROLOL SUCCINATE 134 131 13 8
WARFARIN SODIUM 133 128 14 11
CARVEDILOL 133 130 14 25
PREDNISONE 130 129 16 23
TRAMADOL HCL 122 106 17 21
JANTOVEN 113 102 18 37
GABAPENTIN 113 113 18 18
ATENOLOL 109 105 20 15
CRESTOR 99 96 21 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 91 22 36
CITALOPRAM HBR 91 85 23 20
ALLOPURINOL 90 88 24 22
PROAIR HFA 87 61 25 76
FENTANYL 85 85 S2 26 50
TAMSULOSIN HCL 85 85 26 31
CLOPIDOGREL 84 77 28 34
LOSARTAN POTASSIUM 80 79 29 13
DONEPEZIL HCL 78 77 30 24
LANTUS SOLOSTAR 75 74 31 41
DIGOXIN 73 72 32 26
PEN NEEDLE 72 67 33 57
BUPROPION XL 70 45 34 164
ISOSORBIDE MONONITRATE ER 67 55 35 27
HYDROCODONE-ACETAMINOPHEN 67 58 S3 35 17
AMITRIPTYLINE HCL 65 40 R 37 54
DILTIAZEM ER 64 64 38 85
SPIRIVA 58 53 39 48
HUMALOG 58 57 39 77
DIOVAN 57 54 41 44
CIPROFLOXACIN HCL 57 55 41 60
TRIAMTERENE-HCTZ 57 56 41 30
INSULIN SYRINGE 54 48 44 88
OXYCODONE HCL 54 21 S2 44 114
FELODIPINE ER 54 54 44 128
LOSARTAN-HYDROCHLOROTHIAZIDE 54 34 44 49
METOLAZONE 53 53 48 112
VENLAFAXINE HCL ER 52 42 49 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.